Want to see ES:IZER full AI Analyst Report?
Top Page
Izertis SA
(BME:IZER)
Select Model
Select Model
Rating:54Neutral
Price Target:
€9.00
▼(-15.09% Downside)
Action:Reiterated
Date:04/03/26
The score is driven mainly by solid underlying financial performance (growth and a strong 2025 free-cash-flow rebound) but is held back by balance-sheet leverage and thin net profitability. Technicals are bearish with the stock trading below major moving averages, and valuation is a meaningful headwind due to a high P/E and no dividend support.
Positive Factors
Multi-year revenue scaling
Sustained top-line expansion from ~€50.7M to ~€161.4M demonstrates durable market demand and successful client acquisition. This scale supports investment in capabilities, broadens client footprint, and increases levers for cross-selling higher‑value services, improving long-term revenue stability.
Negative Factors
Elevated leverage
Debt-to-equity ~1.31 with rising absolute debt constrains financial flexibility and increases interest and refinancing exposure. Persistent leverage above ~1.1x limits strategic optionality for M&A or cyclicary downturns and raises vulnerability if cash flow weakens.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year revenue scaling
Sustained top-line expansion from ~€50.7M to ~€161.4M demonstrates durable market demand and successful client acquisition. This scale supports investment in capabilities, broadens client footprint, and increases levers for cross-selling higher‑value services, improving long-term revenue stability.
Read all positive factors
Izertis SA (IZER) vs. iShares MSCI Spain ETF (EWP)
Market Cap
€305.68M
Dividend YieldN/A
Average Volume (3M)15.65K
Price to Earnings (P/E)61.6
Beta (1Y)0.03
Revenue Growth21.31%
EPS Growth-12.38%
CountryES
Employees1,900
SectorTechnology
Sector Strength88
IndustryInformation Technology Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding35,543,983
10 Day Avg. Volume5,836
30 Day Avg. Volume15,646
Financial Highlights & Ratios
PEG Ratio-6.00
Price to Book (P/B)3.15
Price to Sales (P/S)1.82
P/FCF Ratio11.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€11.50Price Target Upside8.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Izertis SA Business Overview & Revenue Model
Company Description
Izertis, S.A., established in 1996 and headquartered in Gijón, Spain, offers a comprehensive range of technology consulting services to clients both domestically and globally. The company's expertise spans digital strategy, data-driven marketing, ...
How the Company Makes Money
Izertis makes money primarily by selling professional services and technology consulting to business and public-sector clients. Its core revenue model is services-led: (1) project-based work where it scopes and delivers defined outcomes (e.g., bui...
Izertis SA Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
52
Neutral
Cash Flow
73
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 161.44M | 133.08M | 117.23M | 88.43M | 65.05M |
| Gross Profit | 49.75M | 42.30M | 37.22M | 25.70M | 17.30M |
| EBITDA | 22.89M | 19.93M | 17.96M | 11.92M | 7.79M |
| Net Income | 3.87M | 4.28M | 5.04M | 3.83M | 2.33M |
Balance Sheet | |||||
| Total Assets | 272.47M | 212.72M | 192.27M | 144.63M | 101.19M |
| Cash, Cash Equivalents and Short-Term Investments | 54.33M | 33.17M | 30.86M | 35.86M | 37.89M |
| Total Debt | 122.43M | 95.18M | 90.01M | 69.59M | 44.44M |
| Total Liabilities | 178.27M | 128.16M | 119.39M | 95.95M | 68.96M |
| Stockholders Equity | 93.33M | 84.24M | 72.65M | 48.48M | 33.48M |
Cash Flow | |||||
| Free Cash Flow | 25.18M | 5.31M | 10.29M | 7.44M | 2.10M |
| Operating Cash Flow | 29.13M | 10.18M | 13.32M | 9.53M | 4.03M |
| Investing Cash Flow | -13.60M | -18.00M | -19.92M | -20.13M | -5.39M |
| Financing Cash Flow | 6.12M | 10.87M | 384.00K | 8.48M | 22.61M |
Izertis SA Technical Analysis
Negative
10.60
Price Trends
8.77
Negative
8.80
Negative
9.34
Negative
Market Momentum
-0.07
Positive
43.60
Neutral
45.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ES:IZER, the sentiment is Negative. The current price of 10.6 is above the 20-day moving average (MA) of 8.82, above the 50-day MA of 8.77, and above the 200-day MA of 9.34, indicating a bearish trend. The MACD of -0.07 indicates Positive momentum. The RSI at 43.60 is Neutral, neither overbought nor oversold. The STOCH value of 45.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ES:IZER.
Izertis SA Peers Comparison
UnderperformOutperform
Sector (61)
ES:IZER
Izertis SA
8.68
-1.82
-17.33%
ES:IDR
Indra Sistemas
47.45
9.53
25.12%
ES:DOM
Global Dominion Access SA
2.88
-0.28
-8.98%
ES:ALC
Altia Consultores S.A.
6.60
0.26
4.05%
ES:SCO
Seresco SA
5.70
-1.14
-16.62%
ES:ATSI
Aplicaciones y Tratamiento de Sistemas, S.A.
4.08
-0.10
-2.39%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.